<DOC>
	<DOCNO>NCT00730028</DOCNO>
	<brief_summary>The purpose clinical trial evaluate 2 different antibiotic , drug fight bacteria , [ clindamycin ( CLINDA ) trimethoprim-sulfamethoxazole ( TMP-SMX ) ] wound care outpatient management uncomplicated skin soft tissue infection ( uSSTIs ) child adult . The study occur area community associate methicillin-resistant Staphylococcus ( S. ) aureus common . S. aureus type bacteria . A total 1310 volunteer , great equal 6 month age adults 85 year young , non-immunocompromised , uSSTIs ( particular abscess and/or cellulitis ) enrol study . Subjects treat one following : CLINDA , TMP-SMX , placebo ( contain medication ) . Volunteers group base presence cellulitis abscess , whether abscess surgically drain , size . The subject participation duration study 6 week .</brief_summary>
	<brief_title>Uncomplicated Skin Soft Tissue Infections Caused Community-Associated Methicillin-Resistant Staphylococcus Aureus</brief_title>
	<detailed_description>Clinical practice treatment community-onset skin soft tissue infection ( SSTI ) keep pace emergence methicillin-resistant Staphylococcus aureus ( MRSA ) community . This clinical trial evaluate clindamycin ( CLINDA ) trimethoprim-sulfamethoxazole ( TMP-SMX ) wound care outpatient management uncomplicated skin soft tissue infection ( uSSTI ) 3 metropolitan area , Chicago , Los Angeles , San Francisco , city high prevalence community acquire ( CA ) -MRSA . This phase IIb multicenter , stratify , randomize , double-blind trial enrol subject abscess cellulitis treat CLINDA , TMP-SMX , placebo . Participants include 1310 non-immunocompromised out-patients age 6 month 85 year SSTIs require hospital admission . Subjects undergo screening/baseline evaluation , include determination presence size abscess and/or presence cellulitis . Subjects randomize receive treatment either CLINDA , TMP-SMX , placebo depend whether : large drainable abscess , define great 5 cm diameter adult great 3 cm diameter age 6-11 month , great 4 cm age 1-8 year , great 5 cm age 9 year old ; limit drainable abscess , define less equal 5 cm adult less equal 3 cm age 6-11 month , less equal 4 cm age 1-8 year , less equal 5 cm age 9 year old ; cellulitis erysipelas . If diameter abscess great 5 cm ( small child depend age ) 2 site skin infection present subject randomize ( 1:1 ) 10 day therapy TMP-SMX CLINDA . If diameter abscess le equal 5 cm ( small child depend age ) subject randomize ( 1:1:1 ) TMP-SMX , CLINDA placebo 10 day . Subjects cellulitis erysipelas randomize ( 1:1 ) TMP-SMX CLINDA 10 day . Subjects provide study drug , instruct use , schedule 4 follow-up visit include : wound check ( 24-48 hour enrollment ) ; end therapy ( 48 hour completion therapy ) ; test cure ( 7-10 day completion therapy ) ; final visit one month completion therapy . The primary objective study : compare cure rate CLINDA TMP-SMX treatment patient cellulitis large abscess Test Cure ( TOC ) visit compare cure rate CLINDA , TMP-SMX , placebo , conjunction surgical drainage treatment subject limit abscess TOC visit .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Staphylococcal Infections</mesh_term>
	<mesh_term>Soft Tissue Infections</mesh_term>
	<mesh_term>Clindamycin</mesh_term>
	<mesh_term>Clindamycin palmitate</mesh_term>
	<mesh_term>Clindamycin phosphate</mesh_term>
	<mesh_term>Methicillin</mesh_term>
	<mesh_term>Trimethoprim , Sulfamethoxazole Drug Combination</mesh_term>
	<mesh_term>Sulfamethoxazole</mesh_term>
	<mesh_term>Trimethoprim</mesh_term>
	<criteria>Age 6 month 85 year . Able complete inform consent process , minor , parent guardian able complete inform consent process ; assent form also complete child age 7 older . Willing able complete study protocol , studyrelated activity , visit . Diagnosis uncomplicated skin soft tissue infection ( uSSTI ) , either cellulitis ( define inflammation skin associate skin structure ) abscess ( define circumscribe collection pu ) , evidence least 2 follow localize sign symptom skin least 24 hour : 1 . Erythema 2 . Swelling induration 3 . Local warmth 4 . Purulent drainage 5 . Tenderness palpation pain Able take oral antibiotic therapy , either pill suspension form . Hospital inpatient . Hospitalization within prior 14 day . Residence longterm skilled nursing facility . Requirement hospitalization skin infection condition . Previous enrollment protocol . Participation another clinical trial within previous 30 day . Superficial skin infection , include : 1 . Impetigo 2 . Ecthyma 3 . Folliculitis 4 . Infections high cure rate surgical incision alone ( isolated furunculosis ) topical local measure Unstable psychiatric psychological condition render subject unlikely cooperative complete study requirement . Active drug alcohol use dependence , opinion site investigator , would interfere adherence subject compliance study requirement . Systolic blood pressure &gt; 180 mm Hg . Systolic blood pressure ( SBP ) less agespecific critical value : 1 . Age 6 11 month : &lt; 70 mm Hg 2 . Age 1 8 year : &lt; 80 mm Hg 3 . Age 9 17 year : &lt; 90 mm Hg 4 . Age great equal 18 year : &lt; 90 mm Hg Heart rate le 45 beat per minute ( BPM ) . Heart rate great agespecific critical value : 1 . Age 6 11 month : &gt; 140 BPM 2 . Age 1 8 year : &gt; 120 BPM 3 . Age 9 17 year : &gt; 120 BPM 4 . Age great equal 18 year : &gt; 120 BPM . Oral temperature ( equivalent rectal , tympanic membrane , axillary ) less 35.5 degree Celsius ( 95.9 degree Fahrenheit ) . Oral temperature ( equivalent rectal , tympanic membrane , axillary ) great agespecific critical value : 1 . Age 6 11 month : &gt; 38.0 degree Celsius ( 100.4 degree Fahrenheit ) 2 . Age 1 8 year : &gt; 38.5 degree Celsius ( 101.3 degree Fahrenheit ) 3 . Age 9 17 year : &gt; 38.5 degree Celsius ( 101.3 degree Fahrenheit ) 4 . Age great equal 18 year : &gt; 38.5 degree Celsius ( 101.3 degree Fahrenheit ) . Documented human witness animal bite past 30 day site infection . Systemic antibacterial therapy antistaphylococcal activity within prior 14 day . The following concomitant medication : warfarin , phenytoin , methotrexate , rosiglitazone sulfonylurea systemically administer antibacterial agent activity staphylococci . Diagnosed suspect disseminate severe Staphylococcus aureus group A streptococcal ( GAS ) infection , include lymphangitic spread skin infection , septicemia , bacteremia , pneumonia , endocarditis , osteomyelitis , septic arthritis , gangrene , necrotizing fasciitis , myositis , serious infection . Infection anatomical skin site require specialized management specialize antimicrobial therapy , include : 1 . Periauricular orbital infection 2 . Perirectal infection 3 . Suspected deep space infection hand foot 4 . Genital infection 5 . Mastitis 6 . Bursitis Radiographic evidence suspicion gas tissue foreign body infection ( note : radiography require screening perform discretion treat physician ) . Gastrointestinal symptom nausea , vomit , diarrhea severity would preclude consumption oral antibiotic . Hypersensitivity history allergic reaction study drug . History glucose6phosphate dehydrogenase ( G6PD ) deficiency . Third trim pregnancy : pregnant woman must gestational age estimate objective mean , e.g . ultrasound , fundal height , woman within 4 week third trim pregnancy , define week 27 pregnancy , eligible . Currently breast feed . Severe morbid obesity body mass index ( BMI ) &gt; 40 kg/m^2 . Complicated skin soft tissue infection , : 1 . Catheter catheter site infection within 30 day placement 2 . Surgical site infection 3 . Known suspected prosthetic device infection 4 . Suspected Gramnegative anaerobic pathogen 5 . Unusual exposure history ( e.g. , underwater injury , fishtank exposure , heavy soil exposure , etc ) 6 . Infection site area underlie skin disease chronic eczema , psoriasis , atopic dermatitis , chronic venous stasis History underlie immunocompromising condition immunodeficiency , example : 1 . Diabetes mellitus 2 . Chronic renal failure , creatinine clearance &lt; 30 ml/min 3 . Renal dialysis within past 180 day 4 . Human immunodeficiency virus ( HIV ) positive either cluster differentiation ( CD ) 4 count &lt; 200 &lt; 4 percent CD4 past 180 day HIVpositive document CD4 count past 4 month 5 . Organ bone marrow transplantation ( ever ) , immunosuppressive therapy within past 180 day , severe liver disease 6 . Other serious underlie disease , determine treat physician investigator</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Methicillin-resistant Staphylococcus aureus ( MRSA ) , cellulitis , abscess , child , elderly</keyword>
</DOC>